Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-08-17

FDA Approved: BETAPACE — Supplemental Application (Legacy Pharma USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for BETAPACE (sotalol hydrochloride) from Legacy Pharma USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Betapace (sotalol)

Snippet

SUPPL AP for BETAPACE (SOTALOL HYDROCHLORIDE)